An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth

Little is known about the trustworthiness of clinical practice guidelines (PGs) relevant to child and youth depression or anxiety. To address this gap, we used systematic review methods to identify all available relevant PGs, quality appraise them, and make recommendations regarding which PGs are trustworthy and should be used by clinicians.

[1]  P. Jensen,et al.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management , 2018, Pediatrics.

[2]  O. Bukstein,et al.  Forward to the Future: Clinical Updates and Clinical Practice Guidelines. , 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  R. Kessler,et al.  Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis , 2017, JAMA psychiatry.

[4]  P. Szatmari,et al.  Is the National Guideline Clearinghouse a Trustworthy Source of Practice Guidelines for Child and Youth Anxiety and Depression? , 2017, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[5]  P. Cuijpers,et al.  Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis , 2016, The Lancet.

[6]  Daniel J. Müller,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder , 2016, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[7]  R. Lam,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder , 2016, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[8]  P. Szatmari,et al.  Practitioner Review: On the trustworthiness of clinical practice guidelines - a systematic review of the quality of methods used to develop guidelines in child and youth mental health. , 2016, Journal of child psychology and psychiatry, and allied disciplines.

[9]  S. Bewley,et al.  Diagnosis and management of depression in children and young people: summary of updated NICE guidance , 2016, British Journal of Sports Medicine.

[10]  L. Thabane,et al.  PREVENTING CHILD AND ADOLESCENT ANXIETY DISORDERS: OVERVIEW OF SYSTEMATIC REVIEWS , 2015, Depression and anxiety.

[11]  R. Porter,et al.  Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders , 2015, The Australian and New Zealand journal of psychiatry.

[12]  Lehana Thabane,et al.  Treating child and adolescent anxiety effectively: Overview of systematic reviews. , 2015, Clinical psychology review.

[13]  D. Classen,et al.  Specialty Society Clinical Practice Guidelines: Time for Evolution or Revolution? , 2015, JAMA.

[14]  J. Cole,et al.  Agency for Healthcare Research and Quality (AHRQ) , 2015 .

[15]  P. Cuijpers,et al.  Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta‐analysis , 2015, World psychiatry : official journal of the World Psychiatric Association.

[16]  A Malizia,et al.  Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines , 2015, Journal of psychopharmacology.

[17]  Heleen Riper,et al.  Internet and Computer-Based Cognitive Behavioral Therapy for Anxiety and Depression in Youth: A Meta-Analysis of Randomized Controlled Outcome Trials , 2015, PloS one.

[18]  G. Salum,et al.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[19]  Young-Min Park,et al.  The Korean Medication Algorithm for Depressive Disorder: second revision. , 2014, Journal of affective disorders.

[20]  P. Blier,et al.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders , 2014, BMC Psychiatry.

[21]  P. Kendall,et al.  Comorbidity of anxiety and depression in children and adolescents: 20 years after. , 2014, Psychological bulletin.

[22]  Jorge L. Acosta,et al.  Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument , 2014, Archives of Dermatological Research.

[23]  B. Stevens,et al.  Pediatric Clinical Practice Guidelines for Acute Procedural Pain: A Systematic Review , 2014, Pediatrics.

[24]  P. Pronovost.  Enhancing physicians' use of clinical guidelines. , 2013, JAMA.

[25]  G. Schulte-Körne,et al.  The treatment of depressive disorders in children and adolescents. , 2013, Deutsches Arzteblatt international.

[26]  Donna Lyons,et al.  Changing Directions, Changing Lives: The Mental Health Strategy for Canada , 2013 .

[27]  G. Aarons,et al.  Dissemination and implementation of evidence-based practices for child and adolescent mental health: a systematic review. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[29]  Michael Pignone,et al.  How to decide whether a clinical practice guideline is trustworthy. , 2013, JAMA.

[30]  P. Shekelle,et al.  Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development , 2012, Implementation Science.

[31]  R. McIntyre,et al.  The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. , 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[32]  Graham Thornicroft,et al.  Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations , 2011, PLoS medicine.

[33]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[34]  Gene Feder,et al.  Development of the AGREE II, part 1: performance, usefulness and areas for improvement , 2010, Canadian Medical Association Journal.

[35]  F. Cluzeau,et al.  Development of the AGREE II, part 2: assessment of validity of items and tools to support application , 2010, Canadian Medical Association Journal.

[36]  J. Weisz,et al.  A meta-systems approach to evidence-based practice for children and adolescents. , 2010, The American psychologist.

[37]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. , 2009, Journal of affective disorders.

[38]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. , 2009, Journal of affective disorders.

[39]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[40]  S. Kutcher,et al.  2008 position paper on using SSRIs in children and adolescents. , 2009, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[41]  U. P. S. T. Force.  Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement , 2009, Pediatrics.

[42]  T. Ford.  Practitioner review: How can epidemiology help us plan and deliver effective child and adolescent mental health services? , 2008, Journal of child psychology and psychiatry, and allied disciplines.

[43]  David Brent,et al.  Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[44]  P. Jensen,et al.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, Assessment, and Initial Management , 2007, Pediatrics.

[45]  M. Trivedi,et al.  Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  G. Bernstein,et al.  Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[47]  J. A. Boer,et al.  Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology , 2005, Journal of psychopharmacology.

[48]  A. Beautrais,et al.  Completed suicide and psychiatric diagnoses in young people: a critical examination of the evidence. , 2005, The American journal of orthopsychiatry.

[49]  G. Walter,et al.  Clinical guidance on the use of antidepressant medications in children and adolescents. , 2005, Australian family physician.

[50]  C. Wathen,et al.  Screening for depression in primary care: recommendation statement from the Canadian Task Force on Preventive Health Care , 2005, Canadian Medical Association Journal.

[51]  D. Fergusson,et al.  Life course outcomes of young people with anxiety disorders in adolescence. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[52]  B. Burns,et al.  Evidence-based practice in child and adolescent mental health services. , 2001, Psychiatric services.

[53]  Alessandro Liberati,et al.  Practice guidelines developed by specialty societies: the need for a critical appraisal , 2000, The Lancet.

[54]  R. Kessler,et al.  The social consequences of psychiatric disorders, III: probability of marital stability. , 1998, The American journal of psychiatry.

[55]  R. Kessler,et al.  Social consequences of psychiatric disorders, I: Educational attainment. , 1995, The American journal of psychiatry.

[56]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[57]  Jacob Cohen,et al.  The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability , 1973 .

[58]  Bibliographic Sources.  Screening for Depression in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement , 2016, Annals of Internal Medicine.

[59]  K. Hannes,et al.  Practitioner review: evidence-based practice guidelines on alcohol and drug misuse among adolescents: a systematic review. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[60]  E. Costello,et al.  Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[61]  Mark Olfson,et al.  Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

[62]  S. Greenfield,et al.  COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES , 2011 .

[63]  Laura A. Levit,et al.  Finding what works in health care : standards for systematic reviews , 2011 .

[64]  R. Gallagher.  Evidence-based psychotherapies for depressed adolescents : A review and clinical guidelines , 2005 .

[65]  D. Pine,et al.  The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. , 1998, Archives of general psychiatry.

[66]  G. Nissen.  Treatment for depression in children and adolescents. , 1986, Psychopathology.